Items Tagged ‘Treanda’

November 18th, 2015

Zydelig® Combined with Treanda and Rituxan Appears Promising in Treatment of Chronic Lymphocytic Leukemia


Following the recommendation by an independent Data Monitoring Committee (DMC), Gilead Sciences, Inc today announced that its Phase 3 clinical study evaluating Zydelig® (idelalisib) added to standard therapy in previously-treated chronic lymphocytic leukemia (CLL) patients will be unblinded early. The DMC recommendation is based upon a predefined interim analysis indicating a benefit in patients receiving […]

View full entry

Tags: Chronic Lymphocytic Leukemia, CLL, News, Phase III clinical trial, rituxan, Treanda, zydelig